Dishman Carbogen Amcis Limited announced on 5 May 2026 that its wholly-owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has successfully completed an unannounced Good Manufacturing Practice (GMP) inspection by China's National Medical Products Administration (NMPA) at its Shanghai facility. The disclosure was made under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.Inspection Overview The unannounced inspection was conducted on 14 April 2026 and encompassed a comprehensive on-site assessment of the Shanghai facility's operations. Key details of the inspection are summarised below: Parameter: Details Inspection Date: 14 April 2026 Inspecting Authority: China's National Medical Products Administration (NMPA) Facility:…